[go: up one dir, main page]

AR020815A1 - PROCEDURE FOR THE TREATMENT OF SCHIZOPHRENIA, AS ALSO MEANS TO BE USED IN THIS PROCEDURE - Google Patents

PROCEDURE FOR THE TREATMENT OF SCHIZOPHRENIA, AS ALSO MEANS TO BE USED IN THIS PROCEDURE

Info

Publication number
AR020815A1
AR020815A1 ARP990105204A ARP990105204A AR020815A1 AR 020815 A1 AR020815 A1 AR 020815A1 AR P990105204 A ARP990105204 A AR P990105204A AR P990105204 A ARP990105204 A AR P990105204A AR 020815 A1 AR020815 A1 AR 020815A1
Authority
AR
Argentina
Prior art keywords
procedure
schizophrenia
treatment
nicotine
administration
Prior art date
Application number
ARP990105204A
Other languages
Spanish (es)
Original Assignee
Lohmann Therapie Syst Lts
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lohmann Therapie Syst Lts filed Critical Lohmann Therapie Syst Lts
Publication of AR020815A1 publication Critical patent/AR020815A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/465—Nicotine; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Psychiatry (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

Se describe la administracion transdérmica de nicotina o de una sal de nicotina o de una mezcla de nicotina y sal de nicotina, para el tratamientode la esquizofrenia. También se revelan un procedimiento y un dispositivo medicinal para dichaadministr acion.The transdermal administration of nicotine or a nicotine salt or a mixture of nicotine and nicotine salt for the treatment of schizophrenia is described. A procedure and a medicinal device for said administration are also disclosed.

ARP990105204A 1998-10-16 1999-10-14 PROCEDURE FOR THE TREATMENT OF SCHIZOPHRENIA, AS ALSO MEANS TO BE USED IN THIS PROCEDURE AR020815A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19847715A DE19847715A1 (en) 1998-10-16 1998-10-16 Treatment of schizophrenia symptoms without side effects, by transdermal administration of nicotine or its salt

Publications (1)

Publication Number Publication Date
AR020815A1 true AR020815A1 (en) 2002-05-29

Family

ID=7884666

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP990105204A AR020815A1 (en) 1998-10-16 1999-10-14 PROCEDURE FOR THE TREATMENT OF SCHIZOPHRENIA, AS ALSO MEANS TO BE USED IN THIS PROCEDURE

Country Status (10)

Country Link
EP (1) EP1121126A1 (en)
JP (1) JP2002527478A (en)
KR (1) KR20010080135A (en)
CN (1) CN1323210A (en)
AR (1) AR020815A1 (en)
AU (1) AU6199299A (en)
BR (1) BR9914570A (en)
CA (1) CA2341855A1 (en)
DE (1) DE19847715A1 (en)
WO (1) WO2000023077A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10110953A1 (en) * 2001-03-07 2002-09-19 Lohmann Therapie Syst Lts Transdermal therapeutic system for the administration of partial dopamine D2 agonists
US7455654B2 (en) * 2003-10-28 2008-11-25 Alza Corporation Method and apparatus for reducing the incidence of tobacco use
IL177071A0 (en) * 2005-08-01 2006-12-10 Nitto Denko Corp Method of preparing a nicotine transdermal preparation
EP2706854A4 (en) * 2011-05-09 2014-12-03 Envivo Pharmaceuticals Inc Treatment of cognitive disorders with certain alpha-7 nicotinic acid receptor agonists in combination with nicotine
CZ309812B6 (en) * 2021-05-25 2023-11-01 Consumer Brands International s.r.o A mixture for the production of nicotine pouches and a method of its production

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4680172A (en) * 1985-03-05 1987-07-14 Ciba-Geigy Corporation Devices and methods for treating memory impairment
US4915950A (en) * 1988-02-12 1990-04-10 Cygnus Research Corporation Printed transdermal drug delivery device
GB9614902D0 (en) * 1996-07-16 1996-09-04 Rhodes John Sustained release composition
US5776956A (en) * 1996-07-30 1998-07-07 Lectec Corporation Use of cotinine in treating psychiatric disorders
US5776957A (en) * 1996-11-15 1998-07-07 The University Of Kentucky Research Foundation Nornicotine enantiomers for use as a treatment for dopamine related conditions and disease states

Also Published As

Publication number Publication date
BR9914570A (en) 2001-07-03
CA2341855A1 (en) 2000-04-27
AU6199299A (en) 2000-05-08
JP2002527478A (en) 2002-08-27
DE19847715A1 (en) 2000-04-20
CN1323210A (en) 2001-11-21
WO2000023077A1 (en) 2000-04-27
KR20010080135A (en) 2001-08-22
EP1121126A1 (en) 2001-08-08

Similar Documents

Publication Publication Date Title
DE69433818D1 (en) COMBINED ACTIVE SUBSTANCES AS A METHOD FOR TARGETED ACTIVE SUBSTANCE RELEASE
CY1118651T1 (en) Azacyclic Compounds for Use in Therapeutic Treatment of Serotonin-Related Diseases
DE60115842D1 (en) VALVE ARRANGEMENT
ATE399553T1 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING DEXTROMETHORPHAN AND QUINIDENE FOR THE TREATMENT OF NEUROLOGICAL DISEASES
ATE332136T1 (en) AGENTS SUCH AS NICOTINAMIDE OR CADPR FOR THE TREATMENT OF SKIN DISEASES
ATE355374T1 (en) THERAPEUTIC AGENTS AND METHODS OF THEIR USE FOR THE TREATMENT OF AMYLOIDOGENIC DISEASES
BR0205722A (en) Prolonged release formulation and method for treating a patient suffering from pain
DK1032376T3 (en) Use of benzhydrylsulfinyl derivatives for the treatment of sleepiness of medicinal origin
DE60143911D1 (en) ANTITUMOR COMPOSITIONS CONTAINING ECTEINASCIDINE 743
CY1108815T1 (en) Sequential Administration of CPT-11 and APO-2L Polypeptide
DE60124387D1 (en) SYNERGISTIC COMBINATION FOR THE TREATMENT OF COLORECTAL CARCINOMA
DE602004016376D1 (en) COMBINATION OF ET-743 WITH 5-FLUOROURACIL PRO DRUGS FOR THE TREATMENT OF CANCER
ATE60713T1 (en) PHARMACEUTICAL COMPOSITION OF GUAR GUM AND OTHER ANTIACIDA FOR THE PROTECTION OF OESO-GASTRO-DUODENAL MUCOUS.
AR020815A1 (en) PROCEDURE FOR THE TREATMENT OF SCHIZOPHRENIA, AS ALSO MEANS TO BE USED IN THIS PROCEDURE
PA8525801A1 (en) PIRAZOL COMPOUNDS, PHARMACEUTICAL COMPOSITIONS, AND METHODS TO MODULATE AND / OR INHIBIT THE ACTIVITY OF ERAB / HADH2
ATE90563T1 (en) MEDICINAL PREPARATION OF ESTER DERIVATIVES OF HECOGENIN AND ITS USE IN THE TREATMENT OF BENIGN PROSTATE HYPERPLASIA.
AR022621A1 (en) PHARMACEUTICAL COMPOSITION CONTAINING DEOXIPEGANINE FOR THE TREATMENT OF NICOTINE DEPENDENCE
ATE228843T1 (en) USE OF DESOXYPEGANINE TO TREAT DRUG DEPENDENCE
ATE302010T1 (en) PHARMACEUTICAL COMPOSITION CONTAINING DEOXYPEGANINE FOR THE TREATMENT OF ALCOHOLISM
DE60216292D1 (en) CALCIUM TRIFLUORACETATE WITH CYTOTOXIC EFFECT
ATE247965T1 (en) PHARMACEUTICAL COMPOSITION CONTAINING PARACETAMOL AND BUSPIRONE HAVING ANALGESIC EFFECT
ATE371446T1 (en) COMPOSITIONS FOR PREVENTING ADHESION
DE69734349D1 (en) TREATMENT OF BONE DRESS WITH ADRENOMEDULLIN
ES2062752T3 (en) PREPARED FROM AN OXYPURINOL SALT IN ORAL FORM FOR THE TREATMENT OF HYPERURICEMIA.
TR200000728T2 (en) The use of IFN-alpha and amantadine in the treatment of chronic hepatitis C.

Legal Events

Date Code Title Description
FB Suspension of granting procedure